All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

GLP-1 Single-Dose Vials: New Option

GLP-1 single-dose vials offer a new affordable option. Learn about pricing, availability, and how they compare to pens and compounded meds.

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team||

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

GLP-1 Single-Dose Vials: New Option custom 2026 header image for GLP-1 Weight Loss
Custom header image for GLP-1 Single-Dose Vials: New Option, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: GLP-1 Single-Dose Vials: New Option

GLP-1 single-dose vials offer a new affordable option. Learn about pricing, availability, and how they compare to pens and compounded meds.

Short answer

GLP-1 single-dose vials offer a new affordable option. Learn about pricing, availability, and how they compare to pens and compounded meds.

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, peptide evidence quality

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

GLP-1 single-dose vials offer a new affordable option. Learn about pricing, availability, and how they compare to pens and compounded meds.

Medically reviewed by Dr. Rachel Torres, PharmD (Clinical Pharmacist, compounding pharmacy specialist

Brand-name GLP-1 manufacturers have introduced single-dose vials as a new way to access their medications. This GLP-1 single dose vials affordable resource covers the important information you need to make informed decisions. GLP-1 single-dose vials aim to be more affordable than pre-filled pen injectors while still offering the brand-name product. This development adds another option to an already complex pricing field.

Key Takeaways: - Understand what are single-dose vials - Pricing and Availability - Vials vs. Pens vs. Compounded: Practical Differences - Who Benefits Most from Single-Dose Vials

If you're weighing your options for GLP-1 access, single-dose vials deserve a spot in your comparison. They sit between full-price pens and compounded alternatives. Understanding the pricing, availability, and practical differences helps you make the best choice for your situation.

What Are Single-Dose Vials?

Traditional brand-name GLP-1 medications come primarily in pre-filled pen injectors. These pens contain multiple doses and include the delivery device. Single-dose vials are a different format: a small glass vial containing one dose of medication that you draw into a syringe yourself.

Both Novo Nordisk and Eli Lilly have explored vial-based options as part of their efforts to expand access and address affordability concerns. The vial format removes the cost of the pen delivery device, which contributes to the overall product price.

With a single-dose vial, you receive one vial per injection. For weekly GLP-1 medications, that means 4 to 5 vials per month. You need your own syringes and needles, which are inexpensive and widely available at pharmacies.

The medication inside the vial is the same formulation as what comes in the pen. The active ingredient, concentration, and quality are identical. The difference is purely in the delivery method and packaging.

This format is familiar to anyone who has experience with peptide injections or compounded medications. Drawing from a vial into a syringe is a straightforward process. If you're new to this, our reconstitution calculator guide covers syringe basics that apply here too.

"GLP-1 receptor agonists represent the most significant advance in obesity pharmacotherapy in decades. For the first time, we have medications that produce weight loss approaching what was previously only achievable through bariatric surgery.") Dr. Robert Kushner, MD, Northwestern University, speaking at ObesityWeek 2023


Free Download: Cost Comparison Spreadsheet A side-by-side comparison of GLP-1 pens vs. Single-dose vials vs. Compounded medications including monthly costs, what is included, and practical differences. Get yours free (we'll email it to you instantly.

[Download Now]


Pricing and Availability

Single-dose vial pricing represents a middle ground in the GLP-1 cost spectrum. Here is how the numbers compare.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for GLP-1 Single-Dose Vials: New Option

Brand-name pens remain the most expensive option at $800 to $1,500+ per month without insurance or savings programs. The pen format includes the convenience of a pre-filled, ready-to-use delivery device.

Single-dose vials are priced lower than pens. Exact pricing varies by manufacturer, dose, and pharmacy. The lower cost reflects the removal of the pen device and simplified packaging. Check with your pharmacy or manufacturer for current vial pricing at your prescribed dose.

Patient Perspective: "My insurance denied Wegovy twice. My provider helped me file a peer-to-peer review appeal with supporting documentation from my labs and BMI history. Third time was approved. Don't give up after the first denial.") Brian C., 45, FormBlends patient (name changed for privacy)

Compounded medications from licensed 503A pharmacies typically cost $150 to $400 per month. These contain compounded formulations of the active ingredient, are prescribed by licensed providers, and are prepared per individual prescription. Compounded options remain the most affordable for most people.

Availability of single-dose vials may vary by pharmacy and location. Not all pharmacies stock the vial format immediately. Check with your local pharmacy or mail-order pharmacy for availability. Your provider can also verify options.

Insurance coverage for single-dose vials follows the same rules as pen coverage. Prior authorization requirements, formulary placement, and cost-sharing tiers apply. The vial format may be on a different formulary tier than the pen, potentially resulting in different copays.

For a in-depth look at all pricing options, read our cheapest GLP-1 options guide or visit our pricing page.

Vials vs. Pens vs. Compounded: Practical Differences

Beyond price, each format has practical pros and cons that affect your daily experience.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Convenience: Pre-filled pens are the most convenient. Dial your dose, inject, and dispose. No drawing from a vial required. Single-dose vials require syringe drawing, which adds a few minutes to the process. Compounded vials may be multi-dose (multiple injections per vial), requiring reconstitution calculator and careful measurement.

Dose flexibility: Pens have fixed dose increments set by the manufacturer. Single-dose vials contain one predetermined dose per vial. Compounded medications offer the most dose flexibility since they're prepared per prescription. If your provider wants a non-standard dose, compounded options accommodate that.

Storage: All GLP-1 medications require refrigeration. Pens and single-dose vials are ready to use from the refrigerator. Multi-dose compounded vials need to be used within 4 to 6 weeks after mixing. Single-dose vials eliminate the concern about multi-dose vial contamination since each vial is used once.

Travel friendliness: Pens are the easiest to travel with since they're self-contained. Single-dose vials require you to carry syringes and needles as well. Both need to stay cold during transport. A small insulated travel case works for all formats.

Waste: Single-dose vials create more packaging waste per injection than multi-dose options. Each injection requires a separate vial, syringe, and needle. Multi-dose vials (common with compounded medications) produce less waste per dose.

If you're currently using the FormBlends app to track your doses, it works with any medication format. Log your injections regardless of whether you use pens, vials, or compounded medications.

Who Benefits Most from Single-Dose Vials

Single-dose vials aren't the best choice for everyone. Here is who benefits most from this format.

Patients whose insurance covers the vial but not the pen. Some insurance plans place vials and pens on different formulary tiers. If the vial has better coverage on your plan, it could save you significant money compared to the pen format.

People comfortable with syringes. If you already inject peptides or have experience drawing from vials, the syringe process is second nature. The slight inconvenience doesn't matter to you, and the cost savings are welcome.

Patients who want brand-name medication at a lower price. If you specifically want the brand-name product but find the pen price prohibitive, single-dose vials offer a less expensive version of the same medication.

People in between insurance and compounded options. If you have partial insurance coverage that makes the vial copay affordable, this may be your sweet spot between paying full price for pens and going the compounded route.

Who may prefer other options: If you value maximum convenience, pens are better. If you want the lowest possible price, compounded medications through providers like FormBlends are typically more affordable. If you need custom dosing, compounded options offer more flexibility.

Compare all your options carefully. Run the numbers for your specific insurance situation using our cost comparison tools. Read our semaglutide complete guide for detailed information about the medication itself regardless of format.

Frequently Asked Questions

Are single-dose vials the same medication as the pen?

Yes. Single-dose vials contain compounded formulations of the active ingredient at the same concentration as the pre-filled pen. The only difference is the delivery format. The vial requires you to draw the medication into a syringe, while the pen is pre-filled and ready to inject.

Do I need a different prescription for vials vs. Pens?

Your provider may need to write the prescription specifying the vial format rather than the pen. The medication name and dose remain the same, but the product NDC number differs. Ask your provider to prescribe the specific format you prefer.

Can I use my existing syringes with single-dose vials?

Standard insulin syringes (U-100) work for most GLP-1 single-dose vials. Verify the correct syringe type with your pharmacist based on the specific product you're prescribed. The volume you draw will depend on the medication concentration.

Are single-dose vials available at all pharmacies?

Availability varies. Major retail pharmacies and mail-order pharmacies are most likely to stock single-dose vials. Smaller independent pharmacies may need to special order them. Check with your preferred pharmacy before your provider writes the prescription.

How do single-dose vials compare to compounded medications in cost?

Compounded medications from licensed 503A pharmacies are typically the most affordable option at $150 to $400 per month. Single-dose vial pricing varies but generally falls between compounded and pen pricing. Your total cost depends on insurance coverage, savings programs, and specific dose requirements.

What's Your Next Move?

You have the information. Now let a licensed provider help you put it into action. FormBlends makes it simple (answer a few questions and get a personalized recommendation.

Take the 2-Minute Quiz →


Medical References

  1. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
  2. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
  3. Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
  4. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. [PubMed | ClinicalTrials.gov | DOI]
  5. Wadden TA, Chao AM, Engel S, et al. Tirzepatide with intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3). Nat Med. 2024. [PubMed | ClinicalTrials.gov | DOI]
  6. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48. [PubMed | ClinicalTrials.gov | DOI]

Sources &. References

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
  2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
  3. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
  4. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
  5. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
  6. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
  7. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2[4] (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
  8. Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3[5] (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
  9. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4[6] (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
  10. Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
  11. Centers for Disease Control and Prevention. Multistate Outbreak of Fungal Meningitis and Other Infections) United States, 2012. MMWR. 2012;61(41):839-842.
  12. U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). Public Law 113-54. November 27, 2013.

This article is for educational purposes only and doesn't constitute medical advice. Always consult with a licensed healthcare provider before starting, changing, or stopping any medication or supplement. FormBlends connects you with licensed providers who can evaluate your individual health needs.

Last updated: 2026-03-24

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Wegovy evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 Single-Dose Vials: New Option, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

GLP-1 Single-Dose Vials: New Option research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

GLP-1 single-dose vials offer a new affordable option. Learn about pricing, availability, and how they compare to pens and compounded meds. Treat "GLP-1 Single-Dose Vials: New Option" as a way to pressure-test a decision before money, medication, or provider access is involved. The article ties cost and coverage, dosing, safety and pharmacy quality back to dosing literacy and clinician follow-up. It belongs in a GLP-1 treatment guide where medication choice, dosing, side effects, monitoring, and insurance rules can change the decision. Because this article has 7 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Keep the final call tied to your own labs, history, medications, and clinician guidance.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify total monthly cost, refill timing, dose escalation pricing, and what is included before paying.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for GLP

This update makes GLP more specific by tying semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, glp to the page's original clinical, cost, access, or comparison angle.

The goal is to make the article more useful for people who already know the headline question and need page-level specifics, not another interchangeable glp-1 weight loss summary.

For 2026 review, the content emphasizes current verification, treatment fit, and patient-safety questions that can be discussed with a qualified provider.

GLP custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for GLP, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering GLP, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.